# Tubilux Pharma Spa – FDA Inspection, Dec 9, 2016

Source: https://www.keypedia.com/records/fda_inspections/tubilux-pharma-spa/8cacdb43-ba42-44ae-b6f2-de41dc44bb1d
Source feed: FDA_Inspections

> FDA inspection 998341 of Tubilux Pharma Spa, December 09, 2016. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 998341
- Company Name: Tubilux Pharma Spa
- Inspection Date: 2016-12-09
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1263915 - 2024-06-14](https://www.keypedia.com/records/fda_inspections/tubilux-pharma-spa/31665e2a-33dc-471b-803b-4709debae59b)
- FDA Inspection 1115090 - 2019-12-10
- [FDA Inspection 1047718 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/tubilux-pharma-spa/6c2d27fc-317a-46ad-85a4-fd3fed10264b)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/tubilux-pharma-spa/83daee41-4a1b-4274-bb2a-3922dcf3e9a4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
